BioCatalystWatch
OGNWorkspace / OGN / OverviewCompany library
Price
Market cap
Next catalystExpected 2026VTAMA (tapinarof) · Data readoutCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

MIUDELLA

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

MIUDELLA

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

OG-8276A

PreINDP1P2P3FilingApproved
ebopiprant (OBE022)

PGF2α receptor

PreINDP1P2P3FilingApproved

Partner / License out

Approved / commercial

Histamine H1 receptor × Alpha-adrenergic receptor

Approved

PreINDP1P2P3FilingApproved

RANKL

Approved

PreINDP1P2P3FilingApproved

RANKL

Approved

PreINDP1P2P3FilingApproved

RANKL

Approved

PreINDP1P2P3FilingApproved

History / paused

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

OGN PR & News

OGN SEC archive